Matrix metalloproteinases in acute coronary syndromes: A new therapeutic target?

International Journal of Cardiology

Volumn 134, Issue 3, 2009, Pages 402-404

  Celik, Turgay ^a   Iyisoy, Atila ^a   Kardesoglu, Ejder ^b   Bugan, Baris ^a   Isik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Acute coronary syndromes; Atherosclerosis; Matrix metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE CORONARY SYNDROME; ARTICLE; ATHEROSCLEROTIC PLAQUE; DRUG MECHANISM; DRUG TARGETING; ENZYME BLOOD LEVEL; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; HUMANS; MATRIX METALLOPROTEINASES;

EID: 67349162520     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.014     Document Type: Article

References (18)

1. Fiotti N., Altamura N., Orlando C., et al. Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. Int J Cardiol 127 (2008) 350-357
2. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation. 92 (1995) 657-671
3. Lee R.T., and Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. (1997) 1859-1867
4. Libby P. Molecular bases of the acute coronary syndromes. Circulation (1995) 2844-2850
5. Armstrong E.J., Morrow D.A., and Sabatine M.S. Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation 113 (2006) e382-e385
6. Creemers E., Cleutjens J., Smits J., and Daemen M. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ Res. 89 (2001) 201-210
7. Galis Z., Sukhova G., Lark M., and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94 (1994) 2493-2503
8. Bayes-Genis A., Conover C.A., Overgaard M.T., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 (2001) 1022-1029
9. Rajavashisth T.B., Xu X.P., Jovinge S., et al. Membrane type 1 matrix metallanoproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 99 (1999) 3103-3108
10. Galis Z., Sukhova G., Kranzhofer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix degrading proteinases. Proc Natl Acad Sci U S A 92 (1995) 402-406
11. Uzui H., Harpf A., Liu M., et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106 (2002) 3024-3030
12. Xu X.P., Meisel S.R., Ong J.M., et al. Oxidized low density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99 (1999) 993-998
13. Moreau M., Brocheriou I., Petit L., Ninio E., Chapman M.J., and Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation 99 (1999) 420-426
14. Herman M.P., Sukhova G.K., Libby P., et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma. A novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104 (2001) 1899-1904
15. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32 (1998) 368-372
16. Soejima H., Ogawa H., Sakamoto T., et al. Increased serum matrix metalloproteinase-1 concentration predicts advanced left ventricular remodeling in patients with acute myocardial infarction. Circ J. 67 (2003) 301-304
17. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97 (1998) 2433-2444
18. Cipollone F., Fazia M., Iezzi A., et al. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation 107 (2003) 1479-1485